The Claim
In adult female mice, 8 weeks of progressive weighted wheel running (PoWeR) significantly improves maximal exercise capacity and absolute grip strength, and these adaptations occur irrespective of intermittent (2 mg/kg once weekly) or frequent (2 mg/kg three times weekly) rapamycin treatment, indicating that rapamycin does not inhibit key physical performance gains from voluntary exercise in this model.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Even when taking rapamycin, female mice still get stronger and fitter from using a weighted exercise wheel — the drug doesn't stop their workout gains.
See the scientific wording
In adult female mice, 8 weeks of progressive weighted wheel running (PoWeR) leads to significant improvements in maximal exercise capacity and absolute grip strength, regardless of whether they are treated with intermittent (2 mg/kg, once weekly) or frequent (2 mg/kg, three times weekly) rapamycin, indicating that rapamycin does not block key physical performance adaptations to voluntary exercise in this model.
What the research says
1 studyStudy: Rapamycin Does Not Compromise Exercise‐Induced Muscular Adaptations in Female Mice
The study found that mice on rapamycin, whether taking it once a week or three times a week, still got just as strong and fit from running as mice not on the drug.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.